Form D · Biotechnology

Sanovas, Inc.

San Rafael, CA · CIK 0001496923

Offering snapshot reported Nov 4, 2015 · SEC filing

Reported sold: $987K
Investors reported: 30
Minimum accepted: $0
First sale: Sep 1, 2015

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$285,699 → $986,700
Reported investors7 → 30

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Nov 4, 2015	Amendment	$986,700	$701,001vs Oct 5, 2015	30	SEC filing
Oct 5, 2015	Initial	$285,699	No comparison	7	SEC filing
Sep 19, 2013	Amendment	$6,448,822	$6,345,822vs Sep 19, 2012	143	SEC filing
Sep 19, 2012	Initial	$103,000	No comparison	1	SEC filing
Jul 22, 2011	Amendment	$2,081,000	$1,731,000vs Jul 23, 2010	56	SEC filing
Jul 23, 2010	Initial	$350,000	No comparison	8	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-248758

Source: Form D, filed Nov 4, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Rob Georges	Director
Larry Gerrans	Executive
Lawrence J. Gerrans	Director, Executive
Erhan Gunday	Executive
Erhan Gundy	Director, Executive
Ken Koen	Director
Bruce A. Nichols	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

2597 Kerner Blvd
San Rafael, CA, 94901